1.89
1.89 (-3.28%)
As of Mar 06, 2024
Proqr Therapeutics N.V. [PRQR]
Source:
Company Overview
To date, we have financed our operations primarily through our initial public and follow-on offerings, our ATM facility and private placements of equity securities, convertible loans, licensing and research collaborations and to a lesser extent through funding from governmental bodies and patient organizations, Foundation Fighting Blindness (FFB) and Netherlands Enterprise Agency (RVO).
Country | Netherlands |
Headquarters | leiden |
Phone Number | 31 88 166 7000 |
Industry | manufacturing |
CEO | Daniel De Boer |
Website | ProQR.com |